VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹103 Cr | ₹112 Cr | ₹80 Cr | ₹77 Cr | ₹39 Cr |
What is the latest Sundry Debtors ratio of VENUS REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹103 Cr |
| Mar2025 | ₹112 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹39 Cr |
How is Sundry Debtors of VENUS REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹103 Cr | -7.96 | |
| Mar2025 | ₹112 Cr | 39.40 | |
| Mar2024 | ₹80 Cr | 5.01 | |
| Mar2023 | ₹77 Cr | 98.60 | |
| Mar2022 | ₹39 Cr | - | |
Compare Sundry Debtors of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,051.3 Cr | -4.5% | -13.2% | 254.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.5% |
-13.2% |
254.1% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses